- What the election means for the public option
- HGSI/GSK Benlysta data seem legitimate
- The House plan allows for Medicare drug price negotiations
- Ed Koch chats politics
- Senator Gregg on the public option chances
- Exclusive: More bad news in store for Medtronic spine
- Bring back Eliot Spitzer
- How to eliminate head injury in football
- The proper symbol for medicine is just one snake and no wings
- Is the TCT following the IOM guidelines to avoid industry bias?
- Surprise: The Dr. Oz show is not bad
- Do the Democrats now support the health insurance industry?
- Scientific American: Unsustainable cancer drug costs
- Fox Business: Doctors should be paid more
- Congressional Health Care Caucus
- Fox Business: What to monitor with swine flu
- Fox Business: FTC scrutiny of the PFE WYE merger
- Fox Business: Obama v McCain
- WSJ.com: The JUPITER trial
- Fox Business: Health of Healthcare
- The Wall Street Journal: Avastin for Breast Cancer
- WSJ.com: video tutorial on dermal fillers and Botox
- The Wall Street Journal: Senator Grassley
- The Wall Street Journal: Knee arthroscopy of no benefit in o
- The Wall Street Journal: JNJ DTC TV ads on Cypher
- ABC News: Steve Jobs of Apple and his cancer
- The Wall Street Journal: Vytorin May Lose Preferred Medicare
- The Wall Street Journal: Senate Inquiry into ACC and CRF
- The Wall Street Journal: Liposuction with Dr. Fodor
- The Wall Street Journal: The Tysabri Re-Launch
- The Wall Street Journal: the Next Biotech to be Acquired?
- The Wall Street Journal: Who is Dr. Jarvik Anyway?
- The Wall Street Journal: ASCO abstracts story
- Forbes: Waiting for ENHANCE
- The Wall Street Journal: Avastin for Brain Cancer